Valiant Lab IPO subscribed 2
时间:2024-06-26 14:44:23 阅读(143)
The Initial Public Offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories was subscribed 2.17 times on the third day of bidding on Friday.
The initial share sale received bids for 1,65,77,925 shares against 76,23,030 shares on offer, as per NSE data.
Price range for the offer is Rs 133-140 a share.
The IPO is an entirely fresh issuance of up to 1.08 crore equity shares.
Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd — and to meet the working capital requirements of the subsidiary company.
Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.
Unistone Capital is the manager to the offer.
Equity shares of the company will be listed on the BSE and the NSE.
上一篇:JK Cement stock falls 6% on 30% fall in Q1 profit; should you buy, sell or hold JK Cement stock-
下一篇:Wipro, Infosys, Vodafone Idea, Adani Ports, SBI Card, NHPC, Balrampur Chini Mills stocks in focus
猜你喜欢
- Techno Electric & Engineering Company gets smart metering and transmission projects worth Rs 1,750 crore
- Benign crude price outlook bodes well for India current account
- Bull run- Investors’ wealth climbs Rs 12
- Bitcoin struggles to recover after near 10% drop
- Jupiter Life Line Hospitals files IPO papers with Sebi; to raise Rs 615-cr via fresh issue
- Technology advancement will disrupt digital wealth management industry
- Kaynes Technology IPO Allotment Today- Check status online, grey market premium; stock listing on 22 Nov
- Jeera prices hit record level on lower output and robust demand
- BHEL, Shakti Pumps, Suzlon Energy, Axis Bank among 127 stocks that hit 52-week highs; 7 touch 52-week lows